Migraine Prevalence
Migraine Prevalence - Related Videos
10:39
3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
0 Views •
Cited by 14 •
2014
In this study, the authors report for the first time a novel 3D-Immersive & Interactive Neuronavigation (3D-IIN) through the impact of a spontaneous migraine headache attack in the μ-opioid system of a patient's brain in vivo.
01:08
Prevalence and Incidence
0 Views •
2025
In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions. Prevalence indicates the proportion of individuals in a population who have a specific disease or health condition at a...
16:13
Modeling Neural Immune Signaling of Episodic and Chronic Migraine Using Spreading Depression In Vitro
0 Views •
Cited by 18 •
2011
Migraine and its transformation to chronic migraine are immense healthcare burdens in need of improved treatment options. We seek to define how neural immune signaling modulates the susceptibility to migraine, modeled in vitro using spreading depression in hippocampal slice cultures, as a means to develop novel therapeutic targets.
05:23
Investigating Migraine-Like Behavior Using Light Aversion in Mice
0 Views •
Cited by 19 •
2021
Rodents are not able to report migraine symptoms. Here, we describe a manageable test paradigm (light/dark and open field assays) to measure light aversion, one of the most common and bothersome symptoms in patients with migraines.
07:35
Evaluation of Colorectal Cancer Risk and Prevalence by Stool DNA Integrity Detection
0 Views •
Cited by 4 •
2020
The presented diagnostic FL-DNA kit is a time-saving and user-friendly method to determine the reliable probability of the presence of colorectal cancer lesions.
FAQs
Point prevalence captures migraine at a particular time, whereas period prevalence covers a defined interval and lifetime prevalence records whether a person has ever experienced it. Choosing among these measures changes the population-level picture researchers obtain, so the selected timeframe must match the epidemiological question being investigated.
Structured surveys, clinical interviews, and medical records provide different routes for identifying possible migraine cases. Applying standardized diagnostic criteria to those sources gives researchers a defined basis for deciding which reports or records count in an estimate. The chosen source and criteria therefore shape how consistently cases are recognized across epidemiological studies.
Comparing estimates across age, sex, and geography shows whether migraine burden is distributed evenly or concentrated in particular groups or locations. These patterns do not by themselves establish a biological cause, but they help neuroscientists formulate questions about migraine biology and risk factors and identify populations that warrant closer study.
An estimate is meaningful only in relation to the population and period from which it was derived. Reporting those boundaries lets readers interpret whether the result reflects a moment, an interval, or lifetime experience and compare patterns across demographic groups without treating unlike measurements as equivalent.
Researchers first define the population and the time frame, then collect information through a structured survey, clinical interview, or medical-record review. Standardized diagnostic criteria are used to identify migraine cases, after which the number of identified cases is related to the population studied. This workflow produces the selected prevalence measure for analysis.
Migraine prevalence data support decisions beyond case counting. Health planners can use them to characterize population-level burden and recognize groups with unmet treatment needs. Investigators can also use the estimates to support migraine biology and risk-factor research, while public health teams can establish a baseline for evaluating prevention strategies and other interventions.